CVS GROUP PLC

Transaction in Own Shares • Nov 14, 2025

National Storage Mechanism | Additional information

RNS Number : 5145H

CVS Group plc

14 November 2025

14 November 2025

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

CVS announces that on 13 November 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

Date of purchase:	13/11/2025
Aggregate number of Ordinary Shares purchased:	25,771
Lowest price paid per share (GBp):	1,150.00
Highest price paid per share (GBp):	1,186.00
Volume weighted average price paid per share (GBp):	1,163.79

CVS intends to cancel all of the purchased Ordinary Shares.

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 71,342,887 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

The total number of voting rights in CVS is therefore 71,342,887 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

Since the commencement of the Share Buyback Programme, the Company has repurchased 397,896 Ordinary Shares in aggregate at a weighted average price of 1,252.09 pence per share.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

Individual transactions:

Number of Ordinary Shares purchased	Transaction price (GBp share)	Time of transaction (UK Time)	Transaction reference number	Trading Venue
264	1180	13/11/2025 08:01:14	1332290881849822	XLON
279	1184	13/11/2025 08:03:36	1332290881850507	XLON
73	1186	13/11/2025 08:08:18	1332290881852583	XLON
546	1186	13/11/2025 08:12:53	1332290881853796	XLON
647	1186	13/11/2025 08:12:53	1332290881853799	XLON
160	1184	13/11/2025 08:12:59	1332290881853814	XLON
104	1182	13/11/2025 08:14:06	1332290881854047	XLON
73	1184	13/11/2025 08:16:01	1332290881854402	XLON
180	1186	13/11/2025 08:23:19	1332290881856414	XLON
542	1184	13/11/2025 08:34:07	1332290881859364	XLON
92	1184	13/11/2025 08:34:07	1332290881859365	XLON
75	1186	13/11/2025 08:58:35	1332290881863693	XLON
42	1184	13/11/2025 09:04:05	1332290881864609	XLON
6	1184	13/11/2025 09:04:05	1332290881864610	XLON
108	1184	13/11/2025 09:04:05	1332290881864611	XLON
870	1180	13/11/2025 09:20:48	1332290881866730	XLON
918	1180	13/11/2025 09:25:59	1332290881867235	XLON
650	1180	13/11/2025 09:25:59	1332290881867240	XLON
195	1174	13/11/2025 09:29:49	1332290881867954	XLON
171	1174	13/11/2025 09:29:49	1332290881867957	XLON
280	1170	13/11/2025 09:45:34	1332290881869711	XLON
208	1168	13/11/2025 09:45:42	1332290881869726	XLON
121	1168	13/11/2025 09:45:42	1332290881869727	XLON
377	1164	13/11/2025 09:52:00	1332290881870571	XLON
25	1164	13/11/2025 09:52:01	1332290881870572	XLON
337	1164	13/11/2025 09:52:56	1332290881870643	XLON
1071	1162	13/11/2025 09:57:03	1332290881871070	XLON
234	1162	13/11/2025 09:57:03	1332290881871075	XLON
25	1162	13/11/2025 09:57:04	1332290881871076	XLON
435	1162	13/11/2025 09:57:05	1332290881871081	XLON
23	1162	13/11/2025 09:57:07	1332290881871092	XLON
435	1162	13/11/2025 09:59:01	1332290881871339	XLON
333	1162	13/11/2025 09:59:40	1332290881871422	XLON
1136	1164	13/11/2025 10:19:34	1332290881873843	XLON
7	1164	13/11/2025 10:19:34	1332290881873844	XLON
18	1164	13/11/2025 10:19:37	1332290881873853	XLON
200	1164	13/11/2025 10:27:13	1332290881874564	XLON
453	1164	13/11/2025 10:29:46	1332290881874880	XLON
682	1164	13/11/2025 10:29:46	1332290881874881	XLON
239	1166	13/11/2025 11:00:24	1332290881878956	XLON
754	1166	13/11/2025 11:00:24	1332290881878957	XLON
260	1164	13/11/2025 11:05:20	1332290881879626	XLON
130	1164	13/11/2025 11:05:20	1332290881879629	XLON
412	1160	13/11/2025 11:34:49	1332290881883132	XLON
165	1160	13/11/2025 11:34:49	1332290881883131	XLON
583	1160	13/11/2025 11:34:50	1332290881883133	XLON
11	1160	13/11/2025 11:34:51	1332290881883134	XLON
480	1160	13/11/2025 11:40:12	1332290881883811	XLON
679	1160	13/11/2025 11:40:12	1332290881883812	XLON
474	1158	13/11/2025 12:00:01	1332290881886345	XLON
744	1158	13/11/2025 12:00:01	1332290881886346	XLON
32	1156	13/11/2025 12:04:36	1332290881886885	XLON
6	1156	13/11/2025 12:06:32	1332290881887053	XLON
199	1156	13/11/2025 12:19:03	1332290881888184	XLON
16	1156	13/11/2025 12:19:04	1332290881888185	XLON
173	1156	13/11/2025 12:25:08	1332290881888750	XLON
296	1156	13/11/2025 12:25:08	1332290881888751	XLON
250	1156	13/11/2025 12:25:08	1332290881888752	XLON
846	1154	13/11/2025 12:38:37	1332290881890606	XLON
237	1154	13/11/2025 12:38:37	1332290881890609	XLON
17	1154	13/11/2025 12:38:40	1332290881890610	XLON
10	1154	13/11/2025 12:38:43	1332290881890615	XLON
244	1154	13/11/2025 12:38:43	1332290881890620	XLON
244	1152	13/11/2025 12:46:23	1332290881891454	XLON
315	1150	13/11/2025 13:01:04	1332290881893165	XLON
784	1152	13/11/2025 13:21:38	1332290881895168	XLON
89	1152	13/11/2025 13:21:38	1332290881895169	XLON
486	1152	13/11/2025 13:34:48	1332290881896556	XLON
107	1152	13/11/2025 13:34:48	1332290881896559	XLON
73	1152	13/11/2025 13:48:59	1332290881898345	XLON
1192	1154	13/11/2025 14:04:47	1332290881900058	XLON
24	1154	13/11/2025 14:04:47	1332290881900059	XLON
784	1152	13/11/2025 14:10:36	1332290881900752	XLON
157	1150	13/11/2025 14:14:44	1332290881901209	XLON
281	1150	13/11/2025 14:26:26	1332290881902602	XLON
202	1150	13/11/2025 14:26:26	1332290881902603	XLON
359	1150	13/11/2025 14:36:41	1332290881905436	XLON
198	1150	13/11/2025 14:36:41	1332290881905439	XLON
77	1150	13/11/2025 14:36:48	1332290881905461	XLON
354	1150	13/11/2025 14:52:57	1332290881909117	XLON
320	1150	13/11/2025 15:28:00	1332290881916539	XLON
73	1150	13/11/2025 15:28:00	1332290881916542	XLON

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                             +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

Berenberg (Joint Broker)                                                                                                                             +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

Camarco (Financial PR)                                                                                             [email protected]

Ginny Pulbrook                                                                                                                                                +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSGPGBUGUPAPGW